TABLE 3.
Clinical Outcomes in Routine Evaluation–Outcome Measure (CORE-OM) scores distribution pre- and post-therapy.
| Non-clinical sample (n = 5) | Clinical sample (n = 65) | ||||||||
| CORE-OM |
Pre-therapy score mean (SD) |
Post-therapy score mean (SD) |
Mean Δ (post-pre) mean (CI) |
Pre-therapy score mean (SD) |
Post-therapy score mean (SD) |
Mean Δ (post-pre) mean (CI) |
t | Effect size | P-value |
| Wellbeing | 1.3 (1.0) | 0.5 (0.4) | −0.8 (−1.7/0.2) | 2.7 (0.7) | 1.1 (0.7) | −1.7 (−1.9/−1.5) | 16.0 | 1.8 | 0.000 |
| Symptoms | 1.1 (0.6) | 0.4 (0.1) | −0.7 (−1.3/0.0) | 2.4 (0.6) | 0.9 (0.6) | −1.5 (−1.8/−1.4) | 15.4 | 1.8 | 0.000 |
| Soc fun | 1.3 (0.7) | 0.4 (0.2) | −0.8 (−1.8/0.2) | 2.1 (0.6) | 0.9 (0.5) | −1.2 (−1.4/−1.0) | 13.3 | 1.7 | 0.000 |
| Risk | 0.2 (0.4) | 0.0 (0.1) | −0.1 (−0.5/0.2) | 0.3 (0.5) | 0.0 (0.2) | −0.2 (−0.4/−0.1) | 3.8 | 0.6 | 0.000 |
| Total – risk scale | 1.3 (0.9) | 0.4 (0.1) | −0.9 (−2.0/0.2) | 2.3 (0.5) | 0.9 (0.5) | −1.4 (−1.5/−1.2) | 15.8 | 2.0 | 0.000 |
| Total score | 0.6 (0.3) | 0.3 (0.1) | −0.2 (−0.7/0.3) | 2.0 (0.5) | 0.8 (0.4) | −1.1 (−1.3/−1.0) | 15.3 | 1.9 | 0.000 |